Sharp, part of UDG Healthcare plc, a global leader in contract packaging and clinical supply services, has received approval from the Medicines and Healthcare Product Regulatory Agency (MHRA) to begin production at its Clinical Services Centre of Excellence in Rhymney, UK.

Following a successful inspection by the MHRA, Sharp can now offer a range of clinical trial and commercial services from the £9.5 million facility including primary and secondary packaging with low humidity control, labellingstorage and distributionQP services as well as controlled drug storage.

The Centre also enables Sharp to offer a broader range of integrated services including serialization and Interactive Response Technology (IRT) solutions for clinical trial management.

Please click here for the full article.